JNJ - Johnson & Johnson highlights psoriasis candidate with long-term data
2024-03-09 13:34:43 ET
More on Johnson & Johnson
- Johnson & Johnson (JNJ) Cowen 44th Annual Health Care Conference (Transcript)
- Johnson & Johnson: A Clean Bill Of Health
- Johnson & Johnson: A High-Quality Dividend King Facing Furious Headwinds
- J&J completes $2B acquisition of ADC developer Ambrx
- Biden to push for expanding Medicare drug pricing program